NCT01749423撤回不适用
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Allergan
- 主要终点
- Number of Headache Days
研究概览
简要总结
This study will evaluate the effectiveness of OnabotulinumtoxinA to prevent headaches in patients with Chronic Migraine.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History of chronic migraines
- •15 or more headache days over a 30 day period
- •A minimum of 2 consecutive treatment cycles of 100 units onabotulinumtoxinA and a minimum of 2 consecutive treatment cycles with the onabotulinumtoxinA dosing between 155 and 195 units
排除标准
- •Any treatment cycle dose of onabotulinumtoxinA greater than 200 units
结局指标
主要结局
Number of Headache Days
时间窗: Up to 56 Weeks
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic MigrainesChronic Migraine, HeadachesNCT01749410Allergan33
已完成
3 期
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)Urinary IncontinenceMultiple SclerosisNeurogenic BladderNCT01600716Allergan144
撤回
不适用
Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical InvestigationWrinkleNCT06385171Global Aesthetics LLC500
已完成
3 期
A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial RhytidesForehead RhytidesGlabellar RhytidesNCT02261467Allergan421
已完成
不适用
Toxin Retrospective StudyNeurogenic BladderNCT03042052Centre d'Investigation Clinique et Technologique 805292